Published in

Kachestvennaya klinicheskaya praktika, 4S, p. 75-80, 2020

DOI: 10.37489/2588-0519-2020-s4-75-80

Links

Tools

Export citation

Search in Google Scholar

Current and future use of umifenovir in patients with COVID-19

Journal article published in 2020 by Y.-U. Y.-U. Kiselev ORCID, K. A. Zagorodnikova ORCID, D. V. Ivashchenko ORCID, A. V. Krykov ORCID, I. N. Sychev ORCID, A. S. Matveev ORCID, K. B. Mirzaev ORCID, V. A. Otdelenov ORCID, V. M. Tsvetov ORCID, A. V. Dmitriev ORCID, V. V. Poroikov ORCID, D. A. Sychev ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.